Programmed Cell Death Ligand 1 (PD-L1) and major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in triple-Negative Breast Cancer
These findings support the potential of PD-L1 and MHC class I expression as prognostic markers for TNBC, offering insights to guide treatment decisions and improve patient outcomes.
Authors
- Supajit Nawapun (ORCID: https://orcid.org/0000-0003-1179-964X)
- Piyapharom Intarawichian (ORCID: https://orcid.org/0000-0002-0181-5573)
- Supinda Koonmee (ORCID: https://orcid.org/0000-0002-7605-4676)
- Chaiwat Aphivatanasiri (ORCID: https://orcid.org/0000-0001-9185-4121)
- Ongart Somintara (ORCID: https://orcid.org/0000-0001-7427-0896)
- Malinee Thanee (ORCID: https://orcid.org/0009-0007-6163-3740)
- Waritta Kunprom
- Payia Chadbunchachai
- Anongporn Wongbuddha
- Ponkrit Kaewkedsri
- Sirawich Jessadapattarakul
Institutions
- Khon Kaen University (TH)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/bctt.s506833
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Khon Kaen University